Overview of the Guarantee Situation
Chongqing Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "Chongqing Pharmaceutical" or "the Company") holds 84.45% of the shares of Chongqing Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "Chongqing Pharmaceutical Shares"), making it the controlling shareholder. The subsidiaries of Chongqing Pharmaceutical Shares engage in pharmaceutical distribution. To ensure the smooth operation of their business, based on their operational plans and funding needs, Chongqing Pharmaceutical's subsidiaries intend to provide a maximum joint liability guarantee of no more than RMB 435,003,000 (which can be recycled within the validity period) for the comprehensive financing credit applications of 42 wholly-owned subsidiaries for the year 2026 (Chongqing Pharmaceutical Shares will guarantee for its subsidiaries or between subsidiaries).
To efficiently and orderly complete the company's guarantee work, in accordance with relevant laws and regulations and the provisions of the company's articles of association, if guarantees are provided by Chongqing Pharmaceutical Shares within the scope of the following guarantee plan, the company's board of directors will propose to the shareholders' meeting to authorize the legal representative to handle matters related to the guarantee in accordance with national laws and regulations, relevant regulations and policies of regulatory authorities, and resolutions of the shareholders' meeting and board of directors. The actual credit limits and terms for each subsidiary will ultimately be subject to the actual approval limits and terms set by the respective credit banks, with a term of one year for recycling. The specific situation is as follows: